Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid

Jörger Messerli, Marianne; Marx, Caterina; Oppliger, Byron; Müller, Martin; Surbek, Daniel; Schoeberlein, Andreina (2016). Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid. Best Practice & Research Clinical Obstetrics & Gynaecology, 31, pp. 30-44. Elsevier 10.1016/j.bpobgyn.2015.07.006

Text Joerger-Messerli2015.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (335kB) | Request a copy

The discovery of mesenchymal stem cells (MSCs) in perinatal sources, such as the amniotic fluid (AF) and the umbilical connective tissue, the so-called Wharton's jelly (WJ), has transformed them into promising stem cell grafts for the application in regenerative medicine. The advantages of AF-MSCs and WJ-MSCs over adult MSCs, such as bone marrow-derived mesenchymal stem cells (BMMSCs), include their minimally invasive isolation procedure, their more primitive cell character without being tumourigenic, their low immunogenicity and their potential autologous application in congenital disorders and when cryopreserved in adulthood. This chapter gives an overview of the biology of AF-MSCs and WJMSCs, and their regenerative potential based on the results of recent preclinical and clinical studies. In the end, open questions concerning the use of WJ-MSCs and AF-MSCs in regenerative medicine will be emphasized.

Interest & Impact

Downloads

22 since deposited on 09 Feb 2016
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item